Wegovy may have highest ‘eye stroke’ and sight loss risk of semaglutide GLP-1 agonists
Odds of ischaemic optic neuropathy nearly 5 times higher than among users of Ozempic And 3 times higher in men than in women, analysis of unintended side effect reports shows Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of ‘eye stroke’ (ischaemic optic neuropathy) and sudden ...

